CD8A and neoplasm: In fact, it has recently been reported that administration of the mutant BRAF inhibitors alone resulted in the increased infiltration of granzyme positive CD8+ T cells in tumors without inhibiting general immune responses, which was correlated with tumor reduction and necrosis (Wilmott et al., 2011; Hong et al., 2012).